10891
|
|
|
Retinoic acid receptor responder 1 |
LXNL, PERG-1, TIG1 |
|
10892
|
|
|
Retinoic acid receptor responder 2 |
HP10433, TIG2 |
|
10893
|
|
|
Arginyl-tRNA synthetase 1 |
ArgRS, DALRD1, HLD9, RARS |
|
10894
|
|
|
Arginyl-tRNA synthetase 2, mitochondrial |
ArgRS, DALRD2, PCH6, PRO1992, RARSL |
|
10895
|
|
|
RAS p21 protein activator 1 |
CM-AVM, CMAVM, CMAVM1, GAP, PKWS, RASA, RASGAP, p120, p120GAP, p120RASGAP |
Arteriovenous hemangioma, Arteriovenous malformations, Basal cell carcinoma, Capillary malformation-arteriovenous malformation, Carcinoma, Squamous cell carcinoma, Developmental venous anomaly, Hereditary hemorrhagic telangiectasia, Hydrops fetalis, Klippel-trenaunay syndrome, Noonan syndrome, Parkes weber syndrome, Port-wine stain, Prostate cancer, Diabetes mellitus type 2 |
10896
|
|
|
RAS p21 protein activator 2 |
GAP1M |
Asthma, Breast cancer, Melanoma, Metabolic syndrome, Multiple myeloma, Noonan syndrome, Osteoarthritis, Ovarian cancer, Ovarian serous carcinoma, Scoliosis, Diabetes mellitus type 2 |
10897
|
|
|
RAS p21 protein activator 3 |
GAP1IP4BP, GAPIII |
|
10898
|
|
|
RAS protein activator like 1 |
RASAL |
|
10899
|
|
|
RAS protein activator like 2 |
NGAP |
|
10900
|
|
|
RAS protein activator like 3 |
- |
|